Cargando…

Are Indian patients with juvenile-onset ankylosing spondylitis taller than reference population?

BACKGROUND & OBJECTIVES: Paucity of growth retardation has been observed by us in patients with juvenile-onset ankylosing spondylitis (JAS) in a tertiary care health centre in south India. We, therefore, undertook this pilot study to assess and compare anthropometry of patients with JAS who were...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandhya, Pulukool, Danda, Debashish, Jeyaseelan, Lakshmanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510725/
https://www.ncbi.nlm.nih.gov/pubmed/26112846
http://dx.doi.org/10.4103/0971-5916.159295
_version_ 1782382226582798336
author Sandhya, Pulukool
Danda, Debashish
Jeyaseelan, Lakshmanan
author_facet Sandhya, Pulukool
Danda, Debashish
Jeyaseelan, Lakshmanan
author_sort Sandhya, Pulukool
collection PubMed
description BACKGROUND & OBJECTIVES: Paucity of growth retardation has been observed by us in patients with juvenile-onset ankylosing spondylitis (JAS) in a tertiary care health centre in south India. We, therefore, undertook this pilot study to assess and compare anthropometry of patients with JAS who were 15 yr and older with that of adult onset ankylosing spondylitis (AAS) and matching Indian reference population. METHODS: Consecutive male patients (December 2009- October 2012) with JAS and AAS fulfilling Modified New York Criteria were selected after applying inclusion and exclusion criteria. Demography and anthropometry were noted. Height of both patient groups as well as their parents and siblings were compared with that of the reference population. Mid-parental height and delta height were derived. Those with delta height of >8.5 cm were compared with the remaining. Multivariate logistic regression was done for variables that were found to be significant by chi-square in bivariate analysis. Similar analysis was done for BMI also. RESULTS: There was no significant difference in anthropometric variables between JAS and AAS groups. Twenty eight of the 30 (93.33%) JAS patients were taller as compared to the reference population. Twenty six (86.67%) AAS patients were taller than the reference population. The mean heights of JAS (170.67 ± 6.94 cm) and AAS (168.2 ± 5.94 cm) patients were significantly higher than the reference value of 163.11 cm; both P<0.001. Logistic regression revealed that tallness in JAS was associated positively with hypermobility (OR=23.46,95%CI 1.2-447.2, P=0.036). No significant association was detected for height in AAS and for BMI in both JAS and AAS groups. INTERPRETATION & CONCLUSIONS: No growth retardation was seen in patients with JAS in our study. Majority of patients with JAS and AAS were taller than reference population. The difference between mean height of JAS and AAS was not significant. Larger studies involving different populations are required to confirm these findings.
format Online
Article
Text
id pubmed-4510725
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-45107252015-07-30 Are Indian patients with juvenile-onset ankylosing spondylitis taller than reference population? Sandhya, Pulukool Danda, Debashish Jeyaseelan, Lakshmanan Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Paucity of growth retardation has been observed by us in patients with juvenile-onset ankylosing spondylitis (JAS) in a tertiary care health centre in south India. We, therefore, undertook this pilot study to assess and compare anthropometry of patients with JAS who were 15 yr and older with that of adult onset ankylosing spondylitis (AAS) and matching Indian reference population. METHODS: Consecutive male patients (December 2009- October 2012) with JAS and AAS fulfilling Modified New York Criteria were selected after applying inclusion and exclusion criteria. Demography and anthropometry were noted. Height of both patient groups as well as their parents and siblings were compared with that of the reference population. Mid-parental height and delta height were derived. Those with delta height of >8.5 cm were compared with the remaining. Multivariate logistic regression was done for variables that were found to be significant by chi-square in bivariate analysis. Similar analysis was done for BMI also. RESULTS: There was no significant difference in anthropometric variables between JAS and AAS groups. Twenty eight of the 30 (93.33%) JAS patients were taller as compared to the reference population. Twenty six (86.67%) AAS patients were taller than the reference population. The mean heights of JAS (170.67 ± 6.94 cm) and AAS (168.2 ± 5.94 cm) patients were significantly higher than the reference value of 163.11 cm; both P<0.001. Logistic regression revealed that tallness in JAS was associated positively with hypermobility (OR=23.46,95%CI 1.2-447.2, P=0.036). No significant association was detected for height in AAS and for BMI in both JAS and AAS groups. INTERPRETATION & CONCLUSIONS: No growth retardation was seen in patients with JAS in our study. Majority of patients with JAS and AAS were taller than reference population. The difference between mean height of JAS and AAS was not significant. Larger studies involving different populations are required to confirm these findings. Medknow Publications & Media Pvt Ltd 2015-04 /pmc/articles/PMC4510725/ /pubmed/26112846 http://dx.doi.org/10.4103/0971-5916.159295 Text en Copyright: © Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Sandhya, Pulukool
Danda, Debashish
Jeyaseelan, Lakshmanan
Are Indian patients with juvenile-onset ankylosing spondylitis taller than reference population?
title Are Indian patients with juvenile-onset ankylosing spondylitis taller than reference population?
title_full Are Indian patients with juvenile-onset ankylosing spondylitis taller than reference population?
title_fullStr Are Indian patients with juvenile-onset ankylosing spondylitis taller than reference population?
title_full_unstemmed Are Indian patients with juvenile-onset ankylosing spondylitis taller than reference population?
title_short Are Indian patients with juvenile-onset ankylosing spondylitis taller than reference population?
title_sort are indian patients with juvenile-onset ankylosing spondylitis taller than reference population?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510725/
https://www.ncbi.nlm.nih.gov/pubmed/26112846
http://dx.doi.org/10.4103/0971-5916.159295
work_keys_str_mv AT sandhyapulukool areindianpatientswithjuvenileonsetankylosingspondylitistallerthanreferencepopulation
AT dandadebashish areindianpatientswithjuvenileonsetankylosingspondylitistallerthanreferencepopulation
AT jeyaseelanlakshmanan areindianpatientswithjuvenileonsetankylosingspondylitistallerthanreferencepopulation